Vanguard Global Advisers »

Aktis Oncology shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Aktis Oncology shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $173k 9.7k 17.89

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
BlackRock
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Geode Capital Management
Avidity Partners Management
AH Capital Management
UBS Group
Arrowpoint Asset Management
Alyeska Investment Group

View all funds holding Aktis Oncology